ghk-cu vial Copper Peptide GHK-Cu Injectable - Team Wellcore

Its extended half-life makes it a research tool for studying sustained amylin-pathway signalling and how it complements incretin-based compounds

Musculoskeletal injury and repair Gastrointestinal mucosal healing Neuroprotection and neural recovery Wound healing and tissue regeneration Anti-inflammatory modulation Key Findings from the Literature 01Consistent tendon, ligament, and bone repair improvements in animal models 022025 pilot human IV study demonstrated safety at 1020mg doses 03FDA Category 2 bulk drug substance active area of clinical investigation 04Upregulates GH receptor density in fibroblasts without altering systemic hormone levels 1 Independent third-party lab reports for this peptide

Selling or representing BPC-157 for human use in Canada is prohibited under the Food and Drugs Act

It is used exclusively in experimental work